In the ever-evolving field of diabetes management, glucagon-like peptide-1 receptor agonists have emerged as a transformative therapeutic class. Among these, retaglutide, retatrutide, and trizepatide represent novel https://donnaotek473837.howeweb.com/39780832/glp-1-receptor-agonists-retaglutide-retatrutide-and-trizepatide